ENTRY       D12619                      Drug
NAME        Ensitrelvir (USAN/INN)
FORMULA     C22H17ClF3N9O2
EXACT_MASS  531.1146
MOL_WEIGHT  531.8777
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
             DG02862  ABCG2 inhibitor
             DG02865  SLCO1B1 inhibitor
             DG02907  SLCO1B3 inhibitor
REMARK      Chemical structure group: DG03269
            Product (DG03269): D12353<JP>
EFFICACY    Antiviral
TARGET      SARS coronavirus 3C-like proteinase [KO:K25015]
  PATHWAY   ko03230(K25015)  Viral genome structure
            ko03262(K25015)  Virion - Coronavirus
            ko05171(K25015)  Coronavirus disease - COVID-19
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION CYP inhibition: CYP3A [HSA:1576 1577 1551]
            Transporter inhibition: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               DG03269  Ensitrelvir
                D12619  Ensitrelvir
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG03269  Ensitrelvir
                D12619  Ensitrelvir
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG03269  Ensitrelvir
                D12619  Ensitrelvir
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               DG03269  Ensitrelvir
                D12619  Ensitrelvir
              DG02862  ABCG2 inhibitor
               DG03269  Ensitrelvir
                D12619  Ensitrelvir
              DG02865  SLCO1B1 inhibitor
               DG03269  Ensitrelvir
                D12619  Ensitrelvir
              DG02907  SLCO1B3 inhibitor
               DG03269  Ensitrelvir
                D12619  Ensitrelvir
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               SARS-CoV 3C protease inhibitor
                D12619  Ensitrelvir (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12619
             Drug transporters
              D12619
            Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               DG03269  Ensitrelvir
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG03269  Ensitrelvir
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG03269  Ensitrelvir
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               DG03269  Ensitrelvir
              DG02862  ABCG2 inhibitor
               DG03269  Ensitrelvir
              DG02865  SLCO1B1 inhibitor
               DG03269  Ensitrelvir
              DG02907  SLCO1B3 inhibitor
               DG03269  Ensitrelvir
DBLINKS     CAS: 2647530-73-0
            PDB-CCD: 7YY
ATOM        37
            1   N4y N    16.1882  -13.8785
            2   C8y C    16.1882  -15.2804
            3   N4y N    17.3798  -15.9813
            4   C8y C    18.6415  -15.2804
            5   N4x N    18.6415  -13.8785
            6   C8y C    17.3798  -13.1775
            7   O5x O    17.3798  -11.7756
            8   O5x O    14.9966  -15.9813
            9   N2b N    19.8331  -15.9813
            10  C1b C    17.3798  -17.3832
            11  C8y C    16.1882  -18.0841
            12  C8x C    14.9966  -17.3832
            13  C8y C    13.7349  -18.0841
            14  C8y C    13.7349  -19.4860
            15  C8x C    14.9265  -20.1870
            16  C8y C    16.1882  -19.4860
            17  X   F    12.4732  -17.3832
            18  X   F    17.3798  -20.1870
            19  X   F    12.5433  -20.1870
            20  C1b C    14.9966  -13.1775
            21  C8y C    13.8050  -13.8084
            22  N5x N    12.4732  -13.4579
            23  N4y N    11.7022  -14.6495
            24  C8x C    12.5433  -15.7009
            25  N5x N    13.8050  -15.2103
            26  C1a C    10.3003  -14.6495
            27  C8y C    21.0948  -15.2804
            28  C8x C    22.2864  -15.9813
            29  C8y C    23.4780  -15.2804
            30  C8y C    23.4780  -13.8785
            31  C8x C    22.2864  -13.1775
            32  C8y C    21.0948  -13.8785
            33  X   Cl   19.8331  -13.1775
            34  C8x C    24.8098  -15.7009
            35  N4y N    25.6509  -14.5794
            36  N5x N    24.8098  -13.3878
            37  C1a C    27.0528  -14.5794
BOND        41
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     6   7 2
            8     2   8 2
            9     4   9 2
            10    3  10 1
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17   11  16 1
            18   13  17 1
            19   16  18 1
            20   14  19 1
            21    1  20 1
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 1
            26   24  25 2
            27   21  25 1
            28   23  26 1
            29    9  27 1
            30   27  28 2
            31   28  29 1
            32   29  30 1
            33   30  31 1
            34   31  32 2
            35   27  32 1
            36   32  33 1
            37   29  34 2
            38   34  35 1
            39   35  36 1
            40   30  36 2
            41   35  37 1
///
